Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-07 |
2024-03 |
0.24 |
N/A |
N/A |
N/A |
2024-02-27 |
2023-12 |
0.83 |
0.86 |
0.03 |
3.61% |
2023-11-07 |
2023-09 |
0.65 |
0.64 |
-0.01 |
-1.54% |
2023-08-08 |
2023-06 |
0.54 |
0.63 |
0.09 |
16.67% |
2023-05-09 |
2023-03 |
0.42 |
0.45 |
0.03 |
7.14% |
2023-02-27 |
2022-12 |
0.7 |
0.75 |
0.05 |
7.14% |
Date |
Firm |
Action |
From |
To |
2023-08-08 |
JP Morgan |
Upgrade |
Overweight |
Overweight |
2023-03-06 |
Canaccord Genuity |
Upgrade |
|
Buy |
2023-03-05 |
Raymond James |
Upgrade |
|
Outperform |
2022-11-08 |
Raymond James |
Upgrade |
|
Outperform |
2022-09-13 |
Argus Research |
Upgrade |
Hold |
Buy |
2022-09-05 |
Wells Fargo |
Upgrade |
Equal-Weight |
Overweight |
Date |
Name |
Relation |
Quantity |
Description |
2024-03-06 |
ANDERSEN SVEND |
Officer |
114.54K |
Conversion of Exercise of derivative security |
2024-03-05 |
BEZERRA EDUARDO GUARITA |
Chief Financial Officer |
12.03K |
Conversion of Exercise of derivative security |
2024-03-05 |
FARRINGTON THOMAS M |
Chief Technology Officer |
10.69K |
Conversion of Exercise of derivative security |
2024-03-05 |
HANSON KYLE L |
General Counsel |
11.14K |
Conversion of Exercise of derivative security |
2024-03-06 |
IVES ALISON |
Officer |
18.01K |
Conversion of Exercise of derivative security |
2024-03-06 |
JANISH RONALD CRAIG |
Officer |
38.36K |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
14.88M |
505.03M |
10.99% |
2023-06-29 |
Blackrock Inc. |
12.62M |
428.44M |
9.32% |
2023-06-29 |
Barrow, Hanley Mewhinney & Strauss, LLC |
7.70M |
261.36M |
5.69% |
2023-06-29 |
Dimensional Fund Advisors LP |
6.63M |
224.92M |
4.89% |
2023-06-29 |
Wolf Hill Capital Management, LP |
5.37M |
182.23M |
3.96% |
2023-06-29 |
State Street Corporation |
4.34M |
147.23M |
3.20% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
iShares Core S&P Midcap ETF |
4.23M |
135.29M |
3.13% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
4.20M |
142.65M |
3.10% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
3.49M |
118.61M |
2.58% |
2023-06-29 |
Vanguard Small Cap Value Index Fund |
2.42M |
82.19M |
1.79% |
2023-06-29 |
Touchstone Funds Group Tr-Touchstone Mid-Cap Fd |
2.07M |
70.28M |
1.53% |
2023-07-30 |
DFA U.S. Small Cap Value Series |
2.04M |
74.66M |
1.50% |
Dividend |
Date |
0.276 |
2024-03-07 |
0.273 |
2023-11-30 |
0.273 |
2023-08-31 |
0.273 |
2023-06-01 |
0.273 |
2023-03-09 |
0.26 |
2022-12-20 |
Split |
Date |
2 : 1 |
1993-08-26 |